Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Meningitis Group Urges Earlier Sale Of Approved Sanofi Pasteur Vaccine

This article was originally published in PharmAsia News

Executive Summary

At a press briefing held at the Ministry of Health, Labor and Welfare Feb 8, Miki Tanaka, president of Guiding Children From Bacterial Meningitis, called for earlier sale of preventative vaccines and expressed dismay at the time taken to put Sanofi Pasteur's Hib vaccine on the market. Approved in Japan in January 2007, the vaccine is still not available. A patient and doctor advocacy group presented MHLW with a petition for Hib vaccine regular inoculations and an earlier approval of pneumococcal vaccination for children. (Click for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel